Showing results (21-30 of 26) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Journal of Clinical Psychopharmacology|January 22, 2008
A pilot study of adjunctive atomoxetine treatment to second-generation antipsychotics for cognitive impairment in schizophreniaJoseph I Friedman, David Carpenter, Jing Lu, et al.The American Journal of Psychiatry|July 17, 2010
The effects of hypertension and body mass index on cognition in schizophreniaJoseph I Friedman, Sylvan Wallenstein, Erin Moshier, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 15, 2014
Biomarker analyses from a randomized, placebo-controlled, phase IIIb trial comparing bevacizumab with or without erlotinib as maintenance therapy for the treatment of advanced non-small-cell lung cancer (ATLAS)Fairooz Kabbinavar, Louis Fehrenbacher, John Hainsworth, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 9, 2013
ATLAS: randomized, double-blind, placebo-controlled, phase IIIB trial comparing bevacizumab therapy with or without erlotinib, after completion of chemotherapy, with bevacizumab for first-line treatment of advanced non-small-cell lung cancerBruce E Johnson, Fairooz Kabbinavar, Louis Fehrenbacher, et al.Schizophrenia Research|June 7, 2011
The effects of hypertension and body mass index on diffusion tensor imaging in schizophreniaCheuk Ying Tang, Joseph I Friedman, David M Carpenter, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 25, 2011
Pimozide augmentation of clozapine inpatients with schizophrenia and schizoaffective disorder unresponsive to clozapine monotherapyJoseph I Friedman, Jean-Pierre Lindenmayer, Frances Alcantara, et al.Pageof 3